|
⚲
|
| Keyboard |
| Cavalier Jason
✚
|
|
|---|---|
| CIK # | 0001883290 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001883290] | |
| 4 | [0001883290] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cavalier Jason | |
| Lyra Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2026-01-06 | Sell | 769 | $3.36 | 2,584 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2025-07-10 | Sell | 684 | $8.91 | 6,094 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2025-01-08 | Grant | 420,000 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2024-10-16 | Grant | 100,000 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Options · derivative
|
2024-01-30 | Grant | 200,000 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2023-01-31 | Grant | 140,000 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2022-02-12 | Grant | 15,605 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Options (Right to Buy) · derivative
|
2021-09-13 | Grant | 104,000 | $0.00 |